リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「STAT3 induces hypoxic preconditioning against oxidative stress in neural stem cells」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

STAT3 induces hypoxic preconditioning against oxidative stress in neural stem cells

福田 憲人 山梨大学 DOI:info:doi/10.34429/00005008

2021.03.23

概要

Introduction
Transplantation of neural stem cells (NSCs) which can differentiate into neurons, astrocytes and oligodendrocytes has been proposed as a promising therapeutic strategy in stroke. However, a hostile microenvironment reduced remarkably the number of surviving transplanted cells. One of the approaches to improve the ability of NSCs to survive in the harsh environment and enhance the therapeutic efficacy is hypoxic preconditioning (HP). HP activates endogenous defense mechanisms that show marked protective effects against multiple insults. Clarification of the molecular mechanisms of HP in NSCs would bring new insights for the improvement of NSCs transplantation therapy; however, the mechanisms have not been completely elucidated. Signal transducer and activator of transcription 3 (STAT3) is a transcription factor activated by various stimulations, which phosphorylate STAT3 on tyrosine residue (Tyr 705) resulting in the induction of various gene expression such as vascular endothelial growth factor (VEGF) and cyclin D1. Previous studies that show the pivotal roles of STAT3 in several models of preconditioning suggest that STAT3 would also play an important role in HP of NSCs; however, it has not been investigated so far. The purpose of present study is to investigate the effect of HP on NSCs against oxidative stress, and to test the hypothesis that STAT3 and its related signals have pivotal roles in HP of NSCs.

Materials and Methods
NSCs were isolated from the subventricular zones of postnatal day1 mice (C57BL/6). The cells were collected and suspended in the medium and grown as neurospheres or adherent monolayers. Cell viability was assessed with a cell proliferation reagent using a water-soluble tetrazolium (WST-1) assay kit. To observe the differentiation of NSCs, differentiated cells were stained with the neuronal marker mitogen-activated protein 2 (MAP2), the astrocytic marker glial fibrillary acidic protein (GFAP), the oligodendrocytic marker neuron-glial antigen 2 (NG2), the immature neural stem cell’s marker nestin.

For the induction of HP, NSCs were incubated under hypoxic conditions (5% O2) for 24 hours. As lethal oxidative stress, cultured NSCs were exposed to H2O2 for 12 hours.
To investigate whether hypoxic conditions enhance cell proliferation, the viability was assessed 0, 24 and 48 hours after HP. After 12 hours oxidative stress, cell injury and viability were investigated by terminal deoxynucleotidyl transferase-mediated uridine 5’-triphosphate-biotin nick end labeling (TUNEL) and WST-1 assays. The phospho-STAT3 (pSTAT3) expression in NSCs after HP was investigated by western blotting. The STAT3 inhibition experiment was performed in order to confirm reduction in the protective effect of NSCs by HP. For the detection of VEGF as a paracrine factor, the concentration of VEGF in the culture media was measured by ELISA. The expression changes of STAT3 and its related signals (JAK2 and cyclin D1) in NSCs after HP with/without inhibition of STAT3 were analyzed using western blotting.

Results
H2O2 significantly increased NSC injury, indicated by TUNEL staining. Conversely, WST-1 assay revealed that cell viability of NSCs was significantly reduced by exposure to H2O2 (n=6, p<0.05 or 0.01). HP significantly increased cell viability of NSCs in WST-1 assay (n=5, p<0.05 or 0.01). TUNEL assay revealed that HP decreased cell death 12 hours after H2O2 exposure (n=5, p<0.05 or 0.01). Further, WST-1 assay showed that HP significantly protected the decrease of cell viability due to H2O2 exposure (n=5, p<0.05 or 0.01). Western blot analysis revealed that the expression of pSTAT3 (Tyr705) was increased 0 to 48 hours after HP (n=5, p<0.05 or 0.01). STAT3 inhibitor peptide reversed protective effects of HP on NSC injury due to lethal oxidative stress. The expression levels of JAK2 and pJAK2 were significantly elevated 24 hours after HP, and STAT3 inhibitor further increased the total expression level of JAK2 (n=5, p<0.05). Cyclin D1 expression was increased after HP, which was significantly inhibited by the STAT3 inhibitor (n=5, p<0.05 or 0.01). Moreover, HP increased VEGF concentration in the culture media investigated by ELISA, and the STAT3 inhibitor suppressed this increase (n=5, p<0.05). Neither HP nor STAT3 inhibitor peptide did not affect the differentiation of NSCs.

この論文で使われている画像

参考文献

1. Banerjee S, Williamson D, Habib N, Gordon M, Chataway J: Human stem cell therapy in ischaemic stroke: a review. Age Ageing 40:7-13, 2011

2. Bernstock JD, Peruzzotti-Jametti L, Ye D, Gessler FA, Maric D, Vicario N, et al: Neural stem cell transplantation in ischemic stroke: A role for preconditioning and cellular engineering. J Cereb Blood Flow Metab 37:2314-2319, 2017

3. Bliss T, Guzman R, Daadi M, Steinberg GK: Cell transplantation therapy for stroke. Stroke 38:817-826, 2007

4. Bromberg J, Darnell JE: The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19:2468-2473, 2000

5. Cai FG, Xiao JS, Ye QF: Effects of ischemic preconditioning on cyclinD1 expression during early ischemic reperfusion in rats. World J Gastroenterol 12:2936-2940, 2006

6. Catalano RD, Johnson MH, Campbell EA, Charnock-Jones DS, Smith SK, Sharkey AM: Inhibition of Stat3 activation in the endometrium prevents implantation: a nonsteroidal approach to contraception. Proc Natl Acad Sci U S A 102:8585-8590, 2005

7. Cheng Z, Li L, Mo X, Zhang L, Xie Y, Guo Q, et al: Non-invasive remote limb ischemic postconditioning protects rats against focal cerebral ischemia by upregulating STAT3 and reducing apoptosis. Int J Mol Med 34:957-966, 2014

8. Darnell JE, Jr.: STATs and gene regulation. Science 277:1630-1635, 1997

9. Day PJ, Cleasby A, Tickle IJ, O'Reilly M, Coyle JE, Holding FP, et al: Crystal structure of human CDK4 in complex with a D-type cyclin. Proc Natl Acad Sci U S A 106:4166-4170, 2009

10. Francis KR, Wei L: Human embryonic stem cell neural differentiation and enhanced cell survival promoted by hypoxic preconditioning. Cell Death Dis 1:e22, 2010

11. Froger N, Matonti F, Roubeix C, Forster V, Ivkovic I, Brunel N, et al: VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons. Scientific Reports 10:12409, 2020

12. Fukunaga A, Uchida K, Hara K, Kuroshima Y, Kawase T: Differentiation and angiogenesis of central nervous system stem cells implanted with mesenchyme into ischemic rat brain. Cell Transplant 8:435-441, 1999

13. Geiseler SJ, Morland C: The Janus Face of VEGF in Stroke. International Journal of Molecular Sciences 19:1362, 2018

14. Harms KM, Li L, Cunningham LA: Murine neural stem/progenitor cells protect neurons against ischemia by HIF-1alpha-regulated VEGF signaling. PLoS One 5:e9767, 2010

15. Hebenstreit D, Horejs-Hoeck J, Duschl A: JAK/STAT-dependent gene regulation by cytokines. Drug News Perspect 18:243-249, 2005

16. Hirayama Y, Ikeda-Matsuo Y, Notomi S, Enaida H, Kinouchi H, Koizumi S: Astrocyte-mediated ischemic tolerance. J Neurosci 35:3794-3805, 2015

17. Horie N, So K, Moriya T, Kitagawa N, Tsutsumi K, Nagata I, et al: Effects of oxygen concentration on the proliferation and differentiation of mouse neural stem cells in vitro. Cell Mol Neurobiol 28:833-845, 2008

18. Kalladka D, Sinden J, Pollock K, Haig C, McLean J, Smith W, et al: Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study. Lancet 388:787- 796, 2016

19. Kim EJ, Raval AP, Perez-Pinzon MA: Preconditioning mediated by sublethal oxygen-glucose deprivation-induced cyclooxygenase-2 expression via the signal transducers and activators of transcription 3 phosphorylation. J Cereb Blood Flow Metab 28:1329-1340, 2008

20. Kim SY, Park HJ, Choi JS, Lee JE, Cha JH, Choi YS, et al: Ischemic preconditioning-induced expression of gp130 and STAT3 in astrocytes of the rat hippocampus. Brain Res Mol Brain Res 129:96-103, 2004

21. Kinouchi H, Epstein CJ, Mizui T, Carlson E, Chen SF, Chan PH: Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci U S A 88:11158-11162, 1991

22. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, et al: Ischemic Tolerance Phenomenon Found in the Brain. Brain Research 528:21-24, 1990

23. Lee HJ, Kim KS, Park IH, Kim SU: Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS One 2:e156, 2007

24. Levy DE, Lee CK: What does Stat3 do? J Clin Invest 109:1143-1148, 2002

25. Li JH, Zhang N, Wang JA: Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy. J Endocrinol Invest 31:103-110, 2008

26. Liu J, Ginis I, Spatz M, Hallenbeck JM: Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide. Am J Physiol Cell Physiol 278:C144-153, 2000

27. McKay R: Stem cells in the central nervous system. Science 276:66-71, 1997

28. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136, 1986

29. Ogunshola OO, Antic A, Donoghue MJ, Fan SY, Kim H, Stewart WB, et al: Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J Biol Chem 277:11410-11415, 2002

30. Reynolds BA, Weiss S: Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255:1707-1710, 1992

31. Sakata H, Narasimhan P, Niizuma K, Maier CM, Wakai T, Chan PH: Interleukin 6-preconditioned neural stem cells reduce ischaemic injury in stroke mice. Brain 135:3298-3310, 2012

32. Savitz SI, Rosenbaum DM, Dinsmore JH, Wechsler LR, Caplan LR: Cell transplantation for stroke. Ann Neurol 52:266-275, 2002

33. Theus MH, Wei L, Cui L, Francis K, Hu X, Keogh C, et al: In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp Neurol 210:656-670, 2008

34. Wakai T, Narasimhan P, Sakata H, Wang E, Yoshioka H, Kinouchi H, et al: Hypoxic preconditioning enhances neural stem cell transplantation therapy after intracerebral hemorrhage in mice. J Cereb Blood Flow Metab 36:2134-2145, 2016

35. Wang G, Zhou D, Wang C, Gao Y, Zhou Q, Qian G, et al: Hypoxic preconditioning suppresses group III secreted phospholipase A2-induced apoptosis via JAK2-STAT3 activation in cortical neurons. J Neurochem 114:1039-1048, 2010

36. Wang JA, Chen TL, Jiang J, Shi H, Gui C, Luo RH, et al: Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacol Sin 29:74-82, 2008

37. Wisel S, Khan M, Kuppusamy ML, Mohan IK, Chacko SM, Rivera BK, et al: Pharmacological Preconditioning of Mesenchymal Stem Cells with Trimetazidine (1-[2,3,4- Trimethoxybenzyl]piperazine) Protects Hypoxic Cells against Oxidative Stress and Enhances Recovery of Myocardial Function in Infarcted Heart through Bcl-2 Expression. Journal of Pharmacology and Experimental Therapeutics 329:543-550, 2009

38. Xuan YT, Guo Y, Han H, Zhu Y, Bolli R: An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci U S A 98:9050-9055, 2001

39. Yagi T, Yoshioka H, Wakai T, Kato T, Horikoshi T, Kinouchi H: Activation of signal transducers and activators of transcription 3 in the hippocampal CA1 region in a rat model of global cerebral ischemic preconditioning. Brain Res 1422:39-45, 2011

40. Yang X, Wang S, Ouyang Y, Tu Y, Liu A, Tian Y, et al: Garcinone D, a natural xanthone promotes C17.2 neural stem cell proliferation: Possible involvement of STAT3/Cyclin D1 pathway and Nrf2/HO-1 pathway. Neurosci Lett 626:6-12, 2016

41. Yu SP, Wei Z, Wei L: Preconditioning strategy in stem cell transplantation therapy. Transl Stroke Res 4:76-88, 2013

42. Yu T, Zuo Y, Cai R, Huang X, Wu S, Zhang C, et al: SENP1 regulates IFN-gamma-STAT1 signaling through STAT3-SOCS3 negative feedback loop. J Mol Cell Biol 9:144-153, 2017

43. Yuan LL, Guan YJ, Ma DD, Du HM: Optimal concentration and time window for proliferation and differentiation of neural stem cells from embryonic cerebral cortex: 5% oxygen preconditioning for 72 hours. Neural Regen Res 10:1516-1522, 2015

44. Zhao Y, Xue Y, Liu Z, Ren S, Guan X, Li M, et al: Role of the Janus kinase 2/signal transducers and activators of transcription 3 pathway in the protective effect of remote ischemia preconditioning against cerebral ischemia-reperfusion injury in rats. Neuroreport 30:664-670, 2019

参考文献をもっと見る